[JAGX] Jaguar Animal Health, Inc.


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 0.65 Change: -0 (-0.03%)
Ext. hours: Change: 0 (0%)

chart JAGX

Refresh chart

Strongest Trends Summary For JAGX

JAGX is in the medium-term down -19% below S&P in 2 months and down -73% below S&P in 5 months and down -94% below S&P in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.24 M Cash From Investing Activities Cash From Operating Activities-1.34 M Gross Profit30 K
Net Profit-3.94 M Operating Profit-2.68 M Total Assets4.84 M Total Current Assets3.98 M
Total Current Liabilities9.21 M Total Debt1.7 M Total Liabilities9.21 M Total Revenue60 K
Technical Data
High 52 week4.85 Low 52 week0.18 Last close0.23 Last change0%
RSI32.27 Average true range0.01 Beta0.27 Volume137.04 K
Simple moving average 20 days-7.42% Simple moving average 50 days-12.57% Simple moving average 200 days-73.66%
Performance Data
Performance Week-5.86% Performance Month-12.21% Performance Quart-48.83% Performance Half-73.53%
Performance Year-89.26% Performance Year-to-date-1.66% Volatility daily3.31% Volatility weekly7.41%
Volatility monthly15.19% Volatility yearly52.61% Relative Volume56.92% Average Volume435.59 K
New High New Low-0.02%


2019-03-20 06:30:00 | Jaguar Completes Filing of CMC Technical Section with FDA for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs

2019-03-18 14:00:00 | Four Healthcare Stocks Heating Up On Monday

2019-03-05 09:00:00 | Jaguar Health, Inc. Reports Voting Results from February 28, 2019 Special Meeting of Stockholders

2019-02-25 12:00:00 | Jaguar Health Announces Adjournment of Special Meeting of Stockholders Until Thursday, February 28, 2019

2019-02-21 14:09:19 | What Kind Of Shareholders Own Jaguar Health, Inc. NASDAQ:JAGX?

2019-01-24 09:00:00 | With the Addition of Mytesi to the Formulary for Florida's AIDS Drug Assistance Program ADAP, Approximately 86% of ADAP-Eligible US Lives Now Have Access to Jaguar Health's FDA-Approved Drug Product

2019-01-22 09:00:00 | Jaguar Health to Present at Noble Capital Markets Annual Investor Conference January 28 in Fort Lauderdale

2019-01-09 08:00:00 | Jaguar Health Receives First Order for First-Generation of Equilevia, the Company's Non-Prescription, Personalized, Premium Product for Total Gut Health in High-Performance Equine Athletes

2019-01-07 08:00:00 | Jaguar Health Provides Fourth Quarter 2018 Commercial Sales Updates

2019-01-03 08:00:00 | Jaguar Health to Present at Biotech Showcase 2019 in San Francisco

2019-01-02 08:00:00 | Jaguar Health to Host Investor Call January 7th at 8 a.m. Eastern to Review 4Q'18 Performance

2018-12-06 08:00:00 | Jaguar Health, Inc. Engages T.R. Winston & Company to Advise on Collaboration, Licensing and Development Activities Related to Mytesi and Crofelemer

2018-11-14 20:05:00 | Jaguar Health, Inc. Reports Third-Quarter 2018 Results

2018-11-13 08:00:00 | Reminder: Jaguar Health, Inc. Will Release 3Q'18 Financial Results After Market on November 14th

2018-10-29 09:00:00 | Jaguar Health, Inc. Expects to File Third-Quarter 2018 Financial Results November 14th

2018-10-29 09:00:00 | The Brilliance Behind a Global Operator of Crypto Exchanges BitMax: Understanding the Trans-Fee Mining Model

2018-10-24 09:00:00 | Jaguar Health, Inc. to Host Investor Meetings at Dawson James Small Cap Growth Conference Tuesday, October 30, 2018 in Jupiter, Florida

2018-10-18 09:25:00 | Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals — Discovering Underlying Factors of Influence

2018-10-02 06:00:00 | Jaguar Health Announces Pricing of $9 Million Underwritten Public Offering

2018-09-26 10:30:00 | These Biotech and Cannabis Stocks Are Skyrocketing

2018-09-25 14:40:00 | Jaguar Health's stock triples after licensing deal, has been halted 13 times for volatility

2018-09-24 16:36:28 | Knight Therapeutics and Jaguar Health Announce Strategic Partnership

2018-09-24 16:30:00 | Knight Therapeutics and Jaguar Health Announce Strategic Partnership

2018-08-27 07:55:00 | Detailed Research: Economic Perspectives on The Michaels Companies, Glu Mobile, Natus Medical, Progenics Pharmaceuticals, QuinStreet, and Jaguar Health — What Drives Growth in Today's Competitive Landscape

2018-07-25 08:00:00 | RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®

2018-07-24 09:00:00 | New Analysis of Data in Over 21,000 People Living with HIV Shows Diarrhea Continues to be an Issue and Has Not Declined Significantly Over Time

2018-07-18 07:20:00 | Free Daily Technical Summary Reports on Iovance Biotherapeutics and Three Other Biotech Stocks

2018-07-16 09:00:00 | Napo Pharmaceuticals to Present New Data at the 22nd International AIDS 2018 Conference

2018-07-16 08:00:00 | Today's Research Reports on Trending Tickers: Zogenix and Momenta Pharmaceuticals

2018-07-12 09:00:00 | Jaguar Health, Inc. Provides Second Quarter 2018 Financial Updates

2018-06-28 09:00:00 | Jaguar Health NASDAQ: JAGX Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product

2018-06-28 09:00:00 | RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

2018-06-25 07:45:00 | Research Report Identifies Glu Mobile, Reliance Steel & Aluminum, FedEx, Jaguar Animal Health, Box, and VirnetX Holding with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-06-20 09:00:00 | Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors

2018-06-18 09:00:00 | Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors

2018-06-15 07:09:00 | Iovance Biotherapeutics and Three Additional Biotech Stocks on Our Research Desk's Radar

2018-06-12 09:00:00 | Napo Pharmaceuticals Presents New Data at the 13th International Conference on HIV Treatment and Prevention Adherence Regarding the Use of Mytesi Crofelemer to Treat Noninfectious Diarrhea in HIV Patients

2018-06-03 08:34:19 | Is Jaguar Health Inc’s NASDAQ:JAGX Balance Sheet Strong Enough To Weather A Storm?

2018-06-01 09:00:00 | Jaguar Health, Inc. Announces 1-for-15 Reverse Stock Split

2018-05-29 09:00:00 | Jaguar Health Appoints Robert J. Griffing Chief Commercialization Officer of Jaguar Subsidiary Napo Pharmaceuticals

2018-05-18 17:24:00 | Jaguar Health, Inc. Reports First-Quarter 2018 Operational Updates and Voting Results from 2018 Annual Meeting of Stockholders

2018-05-15 11:15:18 | Jaguar Health Inc NASDAQ:JAGX: Does The Earnings Decline Make It An Underperformer?

2018-05-15 09:00:00 | ''Under Pressure'' Episode of Merce Uses Comedy to Help People Living with HIV Talk About Diarrhea

2018-05-14 07:10:00 | Free Breakfast Technical Briefing on Intrexon and Three Other Biotech Stocks

2018-05-07 08:15:00 | Research Report Identifies Jaguar Animal Health, Dollar Tree, WPX Energy, Abaxis, Lear, and Baker Hughes with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-04-19 09:00:00 | Experts Highlight that Immune System Activation in Aging Patients Living with HIV/AIDS Triggers Effects Such as _Leaky Gut_, Which Can Lead to Diarrhea

2018-04-10 09:00:00 | Jaguar Subsidiary Napo Pharmaceuticals Signs Agreement with the ADAP Crisis Task Force for Mytesi

2018-04-09 09:00:00 | Recent Publications Indicate that Diarrhea is a Significant and Serious Issue in HIV

2018-04-02 09:00:00 | Jaguar Health Appoints Jonathan B. Siegel to Board of Directors

2018-03-26 06:30:00 | Jaguar Health Announces Up to $16.2 Million in Equity Financings in Separate Private Placement Investments, Including Investment by Sagard Capital Partners, L.P., to Continue Commercialization of FDA-Approved Mytesi